Page last updated: 2024-10-29

iohexol and Anemia

iohexol has been researched along with Anemia in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murakami, R1
Kumita, S1
Hayashi, H1
Sugizaki, K1
Okazaki, E1
Kiriyama, T1
Hakozaki, K1
Tani, H1
Miki, I1
Takeda, M1

Other Studies

1 other study available for iohexol and Anemia

ArticleYear
Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.
    European journal of radiology, 2013, Volume: 82, Issue:10

    Topics: Acute Kidney Injury; Aged; Anemia; Causality; Comorbidity; Contrast Media; Drug-Related Side Effects

2013